IVD Raw Materials Market Report 2026

IVD Raw Materials Market Overview

• IVD Raw Materials market size has reached to $27.47 billion in 2025 • Expected to grow to $43.76 billion in 2030 at a compound annual growth rate (CAGR) of 9.8% • Growth Driver: Surge In Infectious Diseases Driving The Growth Of The Market Due To Increasing Prevalence And Urbanization • Market Trend: Africa's First IVD Facility Boosts Local Diagnostic Manufacturing Capacity • North America was the largest region in 2025 and Asia-Pacific is the fastest growing region.

What Is Covered Under IVD Raw Materials Market?

In vitro diagnostics (IVD) raw materials refer to the fundamental biological and chemical substances required for the production and development of diagnostic assays that examine biological samples outside the human body. These materials are used to support the detection, measurement, or evaluation of analytes in clinical samples for diagnostic, screening, or monitoring purposes. The main products in IVD raw materials are antibodies, antigens, enzymes, proteins, biological buffers, and others. Antibodies in in vitro diagnostic (IVD) raw materials are specialized proteins used to detect and bind specific antigens, enabling the accurate identification of diseases or conditions in diagnostic tests. These include technologies such as molecular diagnostics, clinical chemistry, immunochemistry, and others used by end users such as pharmaceutical and biotechnology companies, diagnostic laboratories, contract research organizations, and others.

What Is The IVD Raw Materials Market Growth Forecast?

The ivd raw materials market size is expected to see strong growth in the next few years. It will grow to $43.76 billion in 2030 at a compound annual growth rate (CAGR) of 9.8%. The growth in the forecast period can be attributed to rising prevalence of chronic and infectious diseases, increasing investment in precision diagnostics, growth of point-of-care testing, expanding biopharmaceutical r&d activities, rising demand for customized ivd raw materials. Major trends in the forecast period include rising demand for high-purity diagnostic reagents, growing adoption of recombinant antibodies and proteins, expansion of molecular diagnostics raw material usage, increasing focus on quality and batch consistency, supply chain diversification for critical ivd inputs.

What Is The Driver Of The IVD Raw Materials Market?

The increasing prevalence of infectious diseases is expected to propel the growth of the IVD raw materials market going forward. Infectious diseases are illnesses caused by harmful microorganisms that can spread from one person or organism to another. The increasing prevalence of infectious diseases is due to rapid urbanization, which contributes to the spread of infectious diseases by increasing population density and straining sanitation and healthcare infrastructure. IVD raw materials play a crucial role in combating infectious diseases by enabling the development of accurate diagnostic tests for early detection and effective disease management. For instance, in March 2024, according to the Centers for Disease Control and Prevention, a US-based government agency, the number of tuberculosis cases increased from 8,320 in 2022 to 9,615 in 2023, representing a rise of 1,295 cases. Therefore, the increasing prevalence of infectious diseases is driving the growth of the IVD raw materials industry.

Key Players In The Global IVD Raw Materials Market

Major companies operating in the ivd raw materials market are Merck KGaA, Thermo Fisher Scientific Inc., Bio-Rad Laboratories Inc., LGC Limited, Neogen Corporation, MP Biomedicals, CUSABIO Technology, Fujirebio, Fapon Biotech, ABclonal Technology, Creative Diagnostics, AIVD Biotech Inc., OPERON, Beijing Diagreat Biotechnology Co. Ltd., Biosynth, Aalto Bio Reagents, Angstrom Biotech, Eximio Biotech, Glentham Life Sciences Limited, OYC Americas Inc., NOVA Biologics Inc., Sino Biological Inc., ACROBiosystems, ProSpec-Tany TechnoGene Ltd.

Global IVD Raw Materials Market Trends and Insights

Major companies operating in the IVD raw materials market are focusing on developing advanced solutions, such as IVD manufacturing facilities, to strengthen regional diagnostic capabilities and support healthcare self-sufficiency. An IVD (in vitro diagnostic) manufacturing facility is a specialized facility where devices and equipment used for diagnosing diseases and conditions through laboratory testing of samples outside the human body are designed, produced, and tested for quality and compliance. For instance, in January 2024, Colexa Biosensor Limited, a Nigeria-based health technology company, partnered with Codix Pharma Limited, a Nigeria-based pharmaceutical manufacturing company, to launch Sub-Saharan Africa's first in vitro diagnostics (IVD) manufacturing facility in Lagos. This facility, which produces the onpoint blood glucose meter and strips, is a significant milestone in Africa’s healthcare industry, designed to address the rising diabetes prevalence and improve diagnostic access. The facility can produce 3.6 million packs annually, with the potential for expansion to 10.8 million packs, focusing initially on meeting the demands of West Africa.

What Are Latest Mergers And Acquisitions In The IVD Raw Materials Market?

In June 2025, Fujirebio Holdings, Inc., a Japan-based in vitro diagnostics (IVD) and life-science technology company, acquired Plasma Services Group, Inc. for an undisclosed amount. With this acquisition, Fujirebio aimed to strengthen its supply chain and solidify its position as a trusted provider of critical and rare biological raw materials for the global IVD and life-science industries. Plasma Services Group is a U.S.-based company specializing in the collection, screening, and supply of high-quality and rare biological materials such as sera and other samples required for control reagents and calibrators for a wide range of diseases, from its FDA-registered and ISO-certified facility in Moorestown, NJ.

What Defines the IVD Raw Materials Market?

The IVD raw materials market consists of sales of protein stabilizers, phosphate-buffered saline, washing buffers, and chelating agents. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What Key Data and Analysis Are Included in the IVD Raw Materials Market Report 2026?

The ivd raw materials market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the ivd raw materials industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.